Related references
Note: Only part of the references are listed.Neuroinflammation and oxidative stress act in concert to promote neurodegeneration in the diabetic retina and optic nerve: galectin-3 participation
Henrique Rocha Mendonca et al.
NEURAL REGENERATION RESEARCH (2020)
Galectin-3 as a prognostic biomarker for diabetic nephropathy
Hossam Hodeib et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease
Antonio Boza-Serrano et al.
ACTA NEUROPATHOLOGICA (2019)
Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease
Yachen Shi et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Assessment of serum galectin-3, methylated arginine and Hs-CRP levels in type 2 diabetes and prediabetes
Mehmet Nuri Atalar et al.
LIFE SCIENCES (2019)
Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment
Leide Caroline dos Santos Picanco et al.
CURRENT MEDICINAL CHEMISTRY (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus
Kathryn C. B. Tan et al.
DIABETOLOGIA (2018)
Galectin-3: mediator of microglia responses in injured brain
Reza Rahimian et al.
DRUG DISCOVERY TODAY (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration
Marina Boziki et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Increased plasma Interleukin-1β level is associated with memory deficits in type 2 diabetic patients with mild cognitive impairment
Sai Tian et al.
PSYCHONEUROENDOCRINOLOGY (2018)
Meloxicam Improves Cognitive Impairment of Diabetic Rats through COX2-PGE2-EPs-cAMP/pPKA Pathway
Huan Li et al.
MOLECULAR PHARMACEUTICS (2018)
Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications
Andrea Tumminia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications
Sherifa A. Hamed
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Inflammation and insulin resistance: New targets encourage new thinking
Andrew M. F. Johnson et al.
BIOESSAYS (2017)
Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective
Rafael Simo et al.
ACTA DIABETOLOGICA (2017)
Cognitive Dysfunction in Older Adults With Diabetes: What a Clinician Needs to Know
Medha N. Munshi
DIABETES CARE (2017)
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance
Pingping Li et al.
CELL (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
The Association of Ideal Cardiovascular Health and Atherogenic Index of Plasma in Rural Population: A Cross-Sectional Study from Northeast China
Ye Chang et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2016)
Diabetes mellitus and cognitive impairments
Elham Saedi et al.
WORLD JOURNAL OF DIABETES (2016)
Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation
Miguel Angel Burguillos et al.
CELL REPORTS (2015)
Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease
Xuexin Wang et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2015)
Nesfatin-1 correlates with hypertension in overweight or obese Han Chinese population
Yanyan Zhao et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2015)
Galectin-3 in diabetic patients
Giuseppe Pugliese et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats
Qingqing Yin et al.
NEUROPHARMACOLOGY (2014)
Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels
Qichen Fang et al.
DIABETES CARE (2013)
Review: Systemic inflammation and Alzheimer's disease
C. Holmes
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Serum proteomics in amnestic mild cognitive impairment
Linda IJsselstijn et al.
PROTEOMICS (2013)
The Role of Galectin-3 as a Marker of Cancer and Inflammation in a Stage IV Ovarian Cancer Patient with Underlying Pro-Inflammatory Comorbidities
Isaac Eliaz
CASE REPORTS IN ONCOLOGY (2013)
Genetic variation in galectin-3 gene associates with cognitive function at old age
Stella Trompet et al.
NEUROBIOLOGY OF AGING (2012)
Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment
Marzia Pesaresi et al.
NEUROBIOLOGY OF AGING (2006)
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease
F. Portet et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Share Paper
